Is compounded tirzepatide still available anywhere legitimate?

While compounded tirzepatide (and compounded semaglutide) is still offered by some pharmacies and telehealth services, it's critical to understand the significant caveats and the stance of regulatory bodies like the FDA.

Here's the breakdown regarding its legitimacy and availability:

1. FDA's Stance: Caution and Warnings

• Not FDA-Approved: The FDA has explicitly stated that compounded versions of tirzepatide are not FDA-approved. This means they have not been evaluated for safety, effectiveness, or quality.
• API Concerns: The FDA has warned that many compounded versions use "tirzepatide salts" or "tirzepatide base," which are not the same active ingredient as the tirzepatide found in the FDA-approved drugs (Mounjaro and Zepbound). These alternative forms have not undergone the rigorous testing required for FDA approval.
• No Shortage Justification: Compounding is generally allowed when there's a shortage of an FDA-approved drug, or for specific patient needs (e.g., allergies to inactive ingredients in the approved version). The FDA has not declared a shortage of the FDA-approved tirzepatide (Mounjaro/Zepbound) that would broadly justify compounding.
• Risks: The FDA has warned about potential risks associated with compounded versions, including unknown purity, potency, sterility, potential contaminants, and adverse events due to unproven ingredients or manufacturing processes.

2. Where it's Still Offered (with extreme caution):

Despite the FDA's warnings, you can still find compounded tirzepatide available from:

• Some Compounding Pharmacies: These are typically state-licensed pharmacies that specialize in creating custom medications. They operate under state pharmacy board regulations, which can vary.
• Telehealth Weight Loss Clinics: Many online platforms and telehealth providers have partnered with compounding pharmacies to offer these drugs, often at a lower cost than the brand-name versions.

Why "Legitimate" is Tricky Here:

While the pharmacies themselves might be legitimate, licensed entities, the product they are compounding (a copy of an FDA-approved drug without FDA oversight and often using unverified ingredients) is where the "legitimacy" question arises from a safety and regulatory perspective.

Recommendation for Consumers:

Given the significant warnings from the FDA and the potential safety concerns:

• Prioritize FDA-Approved Medications: The safest and most legitimate options are the FDA-approved brand-name medications:

  • Mounjaro (tirzepatide) for type 2 diabetes.
  • Zepbound (tirzepatide) for chronic weight management.
  • These have undergone extensive clinical trials and are manufactured under strict quality controls.

• Consult a Licensed Healthcare Provider: Before considering any weight loss or diabetes medication, including compounded versions, speak with a doctor. They can:

  • Assess your medical history and determine if tirzepatide is appropriate for you.
  • Discuss the benefits and risks of all available options.
  • Help you navigate insurance coverage for the FDA-approved versions.
  • Prescribe Mounjaro or Zepbound if clinically indicated.

• Be Skeptical of "Too Good to Be True" Offers: If a compounded version is significantly cheaper or easier to obtain without a thorough medical evaluation, proceed with extreme caution.

In summary, while you might find pharmacies and clinics offering compounded tirzepatide, the FDA strongly advises against it due to significant safety and efficacy concerns, and it lacks the regulatory approval of Mounjaro and Zepbound. Your best and safest bet is to pursue the FDA-approved options under the guidance of a healthcare professional.